A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Pfizer
Celgene
GlaxoSmithKline
University of Wisconsin, Madison
AbbVie
Amgen
Novartis
INSYS Therapeutics Inc
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center